For employers
Private gut health care your people will actually use.
Gut symptoms are common at work and almost never mentioned. Nerva gives every employee clinically validated gut-brain care on their phone: 15 minutes a day for six weeks, no appointments, no one to tell.
- 300,000+ people supported
- 20,000+ referring clinicians
- RCT published in the AJG1
- 4.7 / 5 from 30,000+ member reviews
The picture inside a team of 1,000.
Gut symptoms rarely reach HR, a survey, or a sick-leave code labelled as the problem. The published numbers say they're there.
~400
meet criteria for a disorder of gut-brain interaction: real gut symptoms, without a structural cause on the scan.2
87%
of employed people with IBS report their symptoms cut into their work while they're there.3
1 in 4
of those with IBS have missed work because of it.3
Illustrative: published prevalence and workplace-impact research applied to a hypothetical 1,000-person team.2,3 Not Nerva program data.
Real-world study · presented at DDW
It moves the numbers you watch.
In a retrospective study of over 17,000 Nerva users, completing the program was associated with significant long-term improvements in work absenteeism, presenteeism and overall productivity.5
What your employees receive.
A six-week program built on brain-gut behavioural therapy, the approach clinical guidelines recommend for IBS.6 In the app, with humans behind it.
One 15-minute guided brain-gut session a day for six weeks: on their phone, wherever they are, with no appointment to book.
Short CBT-based lessons and diet guidance, including support for reintroducing foods they've been avoiding.
Check-ins on validated symptom measures show employees their own trajectory across the six weeks.
Our care team screens at intake, reaches out to members who go quiet, and escalates warning signs to a provider.
Every eligible employee can start on day one.
- Eligible
An eligibility list, or open access with a company link. No claims feed, no integration.
- Enrolled
Employees sign up privately in minutes. Nothing to disclose at work.
- Six weeks
A daily 15-minute session, short lessons, and symptom check-ins.
- After
Maintenance access for flare-ups; outcomes roll up into your reporting.
“Within the evidence reviewed, Nerva presented the strongest overall evidence for improving IBS symptoms.”
Peterson Health Technology InstituteVirtual Gastrointestinal Care Solutions, March 20267
Evidence you can take to committee.
81%1of participants met the primary symptom endpoint (≥50-point IBS-SSS improvement), vs 63% on active control.
Randomized controlled trial · N=244 · active control · AJG 2025 Read the research →
- Clinically significant abdominal-pain reduction, vs 35% on control1
- 71%
- Clinical studies on Nerva, indexed on our Research page
- 15+
Not an EAP. Not a wellbeing app.
Your people already have generalist support. Nerva is the condition-specific layer none of it covers.
Next to your EAP
An EAP offers short-course, generalist counselling. Nerva is a defined six-week clinical program for gut symptoms, with screening and escalation behind it.
Next to a wellbeing app
Wellbeing apps offer general content. Nerva treats a specific, common condition, and its outcomes were validated in a published randomised controlled trial.1
Next to telehealth
Telehealth still needs appointments, referrals and clinician supply. Nerva is self-guided daily care with humans for screening and escalation, so every eligible employee can start on day one.
Private for them. Clear for you.
Nobody wants to explain gut symptoms to their manager. The reporting line is built so they never have to.
The employee
Owns their care in full
- Signs up privately from any device, with nothing to disclose at work
- Their symptoms, check-ins and progress stay theirs
- Our care team support runs member-to-Nerva, never through you
The employer
Sees the aggregate picture only
- Uptake, engagement and outcomes at the population level
- Privacy-compliant reporting on an agreed cadence
- No individual-level data. No names. Ever.
Launch without a project plan.
Nerva runs alongside your existing carrier or TPA. No claims feed, no clinical integration, and your team doesn't carry it.
Per enrolled employee. Not PEPM.
You pay for the people who actually use it, with outcome-aligned structures available. The care is software, which is what makes this pricing possible.
- Eligibility list or company link
- Communications templates included
- Aggregate reporting on a cadence
Built in Melbourne. Validated with Monash.
Nerva is Australian-founded and headquartered in Melbourne, and its clinical program was developed and validated in research collaboration with Monash University, with Australian participants.1,10
Common questions.
How is this different from our EAP or a wellbeing app?
They coexist without overlap: your EAP keeps handling generalist support, and Nerva handles one specific, common condition with a defined six-week clinical protocol. Employees who need more than self-guided care are identified at intake screening and routed to a clinician, so nobody is left with an app when they need a person.
What does our team have to do?
Share an eligibility list or a company link, forward the launch communications we draft, and receive aggregate reporting on an agreed cadence. There are no appointments to broker and no clinical integration.
What does the reporting show?
Uptake, engagement and symptom outcomes on validated measures, at the population level only. No individual-level data, no names, ever.
How do we pay?
Per enrolled employee rather than a per-head fee across your whole workforce, with outcome-aligned structures available.
Evaluate Nerva for your population.
A private health insurer? There's a page for you →
References
- Anderson, Ellen J.; Peters, Simone L.; Gibson, Peter R.; Halmos, Emma P. Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome. The American Journal of Gastroenterology 120(2):p 440-448, February 2025. DOI: 10.14309/ajg.0000000000002921
- Sperber, A. D. et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology, 2021;160(1):99–114: over 40% of adults worldwide meet criteria for a disorder of gut-brain interaction (functional gastrointestinal disorder). Per-1,000 figures are that prevalence applied to a hypothetical workforce, for illustration.
- Frändemark, Å. et al. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. The American Journal of Gastroenterology, 2018;113(10):1540–1549: 86.8% of employed IBS patients reported impairment while at work and 24.4% reported missed work due to IBS.
- Peters, S. L.; Gibson, P. R.; Halmos, E. P. App-delivered gut-directed hypnotherapy halves the long-term costs associated with managing Irritable Bowel Syndrome (IBS) symptoms and improves work productivity. Retrospective study of 17,000+ Nerva users, presented at Digestive Disease Week: IBS management costs fell from USD 1,259 to USD 502 over six months, with significant long-term improvements in work absenteeism, presenteeism and overall productivity. Retrospective completer analysis, not a controlled trial.
- Lacy, B. E. et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. The American Journal of Gastroenterology, 2021.
- Peterson Health Technology Institute. Virtual Gastrointestinal Care Solutions Assessment. March 2026.
- Peters, S. L.; Yao, C. K.; Philpott, H.; Yelland, G. W.; Muir, J. G.; Gibson, P. R. Randomised clinical trial: the efficacy of gut-directed hypnotherapy is similar to that of the low FODMAP diet for the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 2016;44(5):447–459. A Monash University trial with Australian participants.